At MDS 2021, researchers shared study results on the prevalence of cognitive dysfunction and depression in patients with restless legs syndrome (RLS) and the impact of RLS severity on these variables.
Anxiety and depression in people with hyperparathyroidism may be related to levels of 2 key hormones in the body, according to researchers.
Children who are older, Black and Hispanic, and from families with lower income who attended school remotely during the pandemic experienced disproportionate mental health difficulties.
Heart failure patients receiving blended collaborative care report significantly better mental health-related quality of life and mood at 12 months versus those receiving usual care.
Researchers compared the effects of 4 contemporary ablative neurosurgical procedures on treatment-resistant psychiatric symptoms.
Severe atopic dermatitis (AD) is associated with symptoms of depression and internalizing behaviors throughout childhood.
Adults with disabilities are disproportionately affected by adverse mental health symptoms and substance use during COVID-19.
Researchers performed a secondary analysis of the AFFINITY trial that assessed the effects of fluoxetine treatment on depression symptoms in patients who recently had a stroke.
Depression in MS may increase the risks for incident vascular disease and mortality, and the effects of depression and MS on all-cause mortality appear to be synergistic.
Rural patients with ischemic heart disease (IHD) have higher levels of state hopelessness, especially those who are unmarried.
